Search

everythinglearnresearchcommunity

for

Search:↓

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

People undergoing chemotherapy need better support and information to cope with hair loss.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Baldness score can't be used to predict prostate size.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

Higher light doses cause more damage to hair follicles, predicting better hair removal results.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

FUE provides minimal scarring and quick recovery in hair transplantation, and surgeons not using it may lag in technology.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.